Real-world outcomes of second-line chemotherapy on advanced biliary tract and gallbladder cancers

0 Views
administrator
administrator
06/25/23

Shahid Ahmed, PhD, MD, FRCPC, FACP, Saskatoon Cancer Center, University of Saskatchewan, Saskatoon, Canada, provides an update on the results of a multicenter retrospective population-based cohort study evaluating the impact of real-world second-line chemotherapy on survival in patients with advanced biliary tract and gallbladder cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next